49. Systemic lupus erythematosus Clinical trials / Disease details
Clinical trials : 993 / Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05458622 (ClinicalTrials.gov) | November 29, 2022 | 13/6/2022 | 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol | 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol | Systemic Lupus Erythematosus (SLE) | Biological: Blood sample;Biological: Urine sample;Biological: Saliva sample;Biological: Stood sample;Procedure: Tissue sample | University Hospital, Brest | NULL | Recruiting | 18 Years | N/A | All | 25 | Phase 3 | France |